Key facts
- This page summarizes Todd Wider's Form 4 filing for ASP Isotopes Inc. (ASPI).
- 4 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 03 Oct 2025, 20:25.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Options Exercise
Tax liability
Sale
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
Options Exercise
Additional SEC filing notes
Footnote F1
Represents shares withheld by the Company in connection with net share settlement to satisfy the exercise price associated with the reporting person's exercise of a stock option.
Footnote F2
The sale of shares reported in this Form 4 includes an amount for the purpose of satisfying the reporting person's income tax liabilities resulting from the vesting of a previously granted restricted stock award and the exercise of a stock option issued pursuant to an issuer equity incentive plan.
Footnote F3
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.37 to $9.40, inclusive. The reporting person undertakes to provide ASP Isotopes Inc. (the "Company"), any stockholder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnote 3.
Footnote F4
These options vested in a single installment 12 months after the grant date. The option was granted on April 4, 2022.